The global Nasal Spray Live Attenuated Influenza Vaccine market was valued at US$ 718.5 million in 2023 and is anticipated to reach US$ 1132.6 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.

Nasal Spray Live Attenuated Influenza Vaccine Market

Nasal Spray Live Attenuated Influenza Vaccine (LAIV), often marketed under the brand name FluMist, is a type of influenza vaccine designed to protect against the influenza virus. Unlike traditional injectable influenza vaccines, which contain inactivated (killed) virus particles, LAIV contains a weakened, live influenza virus. This live virus is attenuated, meaning it has been modified to reduce its virulence (ability to cause disease) while still retaining the capacity to stimulate an immune response.

Fluctuating Usage: The use of LAIV has seen fluctuations in recent years. In the United States, for example, there was a period when the Advisory Committee on Immunization Practices (ACIP) recommended against the use of LAIV due to concerns about its effectiveness against certain influenza strains. Subsequently, ACIP reinstated its recommendation for LAIV, but these fluctuations have had an impact on the market.

Pediatric Vaccination: LAIV has been particularly popular for pediatric vaccination. Its non-invasive administration method (nasal spray) has made it a preferred choice for children who may have needle phobias or resistance to traditional injectable vaccines.

Global Market Variation: The availability and popularity of LAIV can vary by country and region. Some countries have embraced LAIV more enthusiastically than others, influenced by factors like regulatory approvals, healthcare policies, and local preferences.

Combination Vaccines: Research is ongoing in developing combination vaccines that may include LAIV alongside other vaccines, such as those for COVID-19. These combination vaccines aim to simplify the vaccination process and increase immunization coverage.

This report aims to provide a comprehensive presentation of the global market for Nasal Spray Live Attenuated Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Spray Live Attenuated Influenza Vaccine.

Report Scope

The Nasal Spray Live Attenuated Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nasal Spray Live Attenuated Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nasal Spray Live Attenuated Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nasal Spray Live Attenuated Influenza Vaccine Market Report

Report Metric	Details
Report Name	Nasal Spray Live Attenuated Influenza Vaccine Market
Accounted market size in 2023	US$ 718.5 million
Forecasted market size in 2030	US$ 1132.6 million
CAGR	6.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Trivalent Flu Vaccine Quadrivalent Flu Vaccine
Segment by Application	Hospital Clinic Public Health Agency Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline, Serum Institute, Fluenz Tetra, BioDiem, FluMist, ChangChun High & New Technology, BCHT Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nasal Spray Live Attenuated Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nasal Spray Live Attenuated Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Nasal Spray Live Attenuated Influenza Vaccine Market growing?

Ans: The Nasal Spray Live Attenuated Influenza Vaccine Market witnessing a CAGR of 6.8% during the forecast period 2024-2030.

What is the Nasal Spray Live Attenuated Influenza Vaccine Market size in 2030?

Ans: The Nasal Spray Live Attenuated Influenza Vaccine Market size in 2030 will be US$ 1132.6 million.

Who are the main players in the Nasal Spray Live Attenuated Influenza Vaccine Market report?

Ans: The main players in the Nasal Spray Live Attenuated Influenza Vaccine Market are Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline, Serum Institute, Fluenz Tetra, BioDiem, FluMist, ChangChun High & New Technology, BCHT Biotechnology

What are the Application segmentation covered in the Nasal Spray Live Attenuated Influenza Vaccine Market report?

Ans: The Applications covered in the Nasal Spray Live Attenuated Influenza Vaccine Market report are Hospital, Clinic, Public Health Agency, Others

What are the Type segmentation covered in the Nasal Spray Live Attenuated Influenza Vaccine Market report?

Ans: The Types covered in the Nasal Spray Live Attenuated Influenza Vaccine Market report are Trivalent Flu Vaccine, Quadrivalent Flu Vaccine

1 Nasal Spray Live Attenuated Influenza Vaccine Market Overview

1.1 Product Overview and Scope of Nasal Spray Live Attenuated Influenza Vaccine

1.2 Nasal Spray Live Attenuated Influenza Vaccine Segment by Type

1.2.1 Global Nasal Spray Live Attenuated Influenza Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Trivalent Flu Vaccine

1.2.3 Quadrivalent Flu Vaccine

1.3 Nasal Spray Live Attenuated Influenza Vaccine Segment by Application

1.3.1 Global Nasal Spray Live Attenuated Influenza Vaccine Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Public Health Agency

1.3.5 Others

1.4 Global Nasal Spray Live Attenuated Influenza Vaccine Market Size Estimates and Forecasts

1.4.1 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue 2019-2030

1.4.2 Global Nasal Spray Live Attenuated Influenza Vaccine Sales 2019-2030

1.4.3 Global Nasal Spray Live Attenuated Influenza Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Nasal Spray Live Attenuated Influenza Vaccine Market Competition by Manufacturers

2.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Nasal Spray Live Attenuated Influenza Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Nasal Spray Live Attenuated Influenza Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Nasal Spray Live Attenuated Influenza Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nasal Spray Live Attenuated Influenza Vaccine, Product Type & Application

2.7 Nasal Spray Live Attenuated Influenza Vaccine Market Competitive Situation and Trends

2.7.1 Nasal Spray Live Attenuated Influenza Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Nasal Spray Live Attenuated Influenza Vaccine Players Market Share by Revenue

2.7.3 Global Nasal Spray Live Attenuated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nasal Spray Live Attenuated Influenza Vaccine Retrospective Market Scenario by Region

3.1 Global Nasal Spray Live Attenuated Influenza Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Nasal Spray Live Attenuated Influenza Vaccine Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Region: 2019-2030

3.2.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Region: 2019-2024

3.2.2 Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Region: 2025-2030

3.3 Global Nasal Spray Live Attenuated Influenza Vaccine Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Region: 2019-2030

3.3.1 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Region: 2019-2024

3.3.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Region: 2025-2030

3.4 North America Nasal Spray Live Attenuated Influenza Vaccine Market Facts & Figures by Country

3.4.1 North America Nasal Spray Live Attenuated Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2019-2030)

3.4.3 North America Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Nasal Spray Live Attenuated Influenza Vaccine Market Facts & Figures by Country

3.5.1 Europe Nasal Spray Live Attenuated Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2019-2030)

3.5.3 Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Nasal Spray Live Attenuated Influenza Vaccine Market Facts & Figures by Country

3.7.1 Latin America Nasal Spray Live Attenuated Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Nasal Spray Live Attenuated Influenza Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Nasal Spray Live Attenuated Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Type (2019-2030)

4.1.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Type (2019-2024)

4.1.2 Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Type (2025-2030)

4.1.3 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Type (2019-2030)

4.2.1 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Type (2019-2024)

4.2.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Type (2025-2030)

4.2.3 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Nasal Spray Live Attenuated Influenza Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Application (2019-2030)

5.1.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Application (2019-2024)

5.1.2 Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Application (2025-2030)

5.1.3 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Application (2019-2030)

5.2.1 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Application (2019-2024)

5.2.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Application (2025-2030)

5.2.3 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Nasal Spray Live Attenuated Influenza Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Sanofi Pasteur

6.1.1 Sanofi Pasteur Corporation Information

6.1.2 Sanofi Pasteur Description and Business Overview

6.1.3 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product Portfolio

6.1.5 Sanofi Pasteur Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Corporation Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 CSL

6.3.1 CSL Corporation Information

6.3.2 CSL Description and Business Overview

6.3.3 CSL Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 CSL Nasal Spray Live Attenuated Influenza Vaccine Product Portfolio

6.3.5 CSL Recent Developments/Updates

6.4 Abbott

6.4.1 Abbott Corporation Information

6.4.2 Abbott Description and Business Overview

6.4.3 Abbott Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Abbott Nasal Spray Live Attenuated Influenza Vaccine Product Portfolio

6.4.5 Abbott Recent Developments/Updates

6.5 GlaxoSmithKline

6.5.1 GlaxoSmithKline Corporation Information

6.5.2 GlaxoSmithKline Description and Business Overview

6.5.3 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product Portfolio

6.5.5 GlaxoSmithKline Recent Developments/Updates

6.6 Serum Institute

6.6.1 Serum Institute Corporation Information

6.6.2 Serum Institute Description and Business Overview

6.6.3 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product Portfolio

6.6.5 Serum Institute Recent Developments/Updates

6.7 Fluenz Tetra

6.6.1 Fluenz Tetra Corporation Information

6.6.2 Fluenz Tetra Description and Business Overview

6.6.3 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product Portfolio

6.7.5 Fluenz Tetra Recent Developments/Updates

6.8 BioDiem

6.8.1 BioDiem Corporation Information

6.8.2 BioDiem Description and Business Overview

6.8.3 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product Portfolio

6.8.5 BioDiem Recent Developments/Updates

6.9 FluMist

6.9.1 FluMist Corporation Information

6.9.2 FluMist Description and Business Overview

6.9.3 FluMist Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.9.4 FluMist Nasal Spray Live Attenuated Influenza Vaccine Product Portfolio

6.9.5 FluMist Recent Developments/Updates

6.10 ChangChun High & New Technology

6.10.1 ChangChun High & New Technology Corporation Information

6.10.2 ChangChun High & New Technology Description and Business Overview

6.10.3 ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.10.4 ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Product Portfolio

6.10.5 ChangChun High & New Technology Recent Developments/Updates

6.11 BCHT Biotechnology

6.11.1 BCHT Biotechnology Corporation Information

6.11.2 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Description and Business Overview

6.11.3 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.11.4 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product Portfolio

6.11.5 BCHT Biotechnology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Nasal Spray Live Attenuated Influenza Vaccine Industry Chain Analysis

7.2 Nasal Spray Live Attenuated Influenza Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nasal Spray Live Attenuated Influenza Vaccine Production Mode & Process

7.4 Nasal Spray Live Attenuated Influenza Vaccine Sales and Marketing

7.4.1 Nasal Spray Live Attenuated Influenza Vaccine Sales Channels

7.4.2 Nasal Spray Live Attenuated Influenza Vaccine Distributors

7.5 Nasal Spray Live Attenuated Influenza Vaccine Customers

8 Nasal Spray Live Attenuated Influenza Vaccine Market Dynamics

8.1 Nasal Spray Live Attenuated Influenza Vaccine Industry Trends

8.2 Nasal Spray Live Attenuated Influenza Vaccine Market Drivers

8.3 Nasal Spray Live Attenuated Influenza Vaccine Market Challenges

8.4 Nasal Spray Live Attenuated Influenza Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

ChangChun High & New Technology

List of Tables

Table 1. Global Nasal Spray Live Attenuated Influenza Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Nasal Spray Live Attenuated Influenza Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Nasal Spray Live Attenuated Influenza Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K L) of Key Manufacturers (2019-2024)

Table 5. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Nasal Spray Live Attenuated Influenza Vaccine Average Price (US$/ml) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Nasal Spray Live Attenuated Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Nasal Spray Live Attenuated Influenza Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Nasal Spray Live Attenuated Influenza Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Nasal Spray Live Attenuated Influenza Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Nasal Spray Live Attenuated Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Spray Live Attenuated Influenza Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Region (2019-2024) & (K L)

Table 18. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Region (2025-2030) & (K L)

Table 20. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2019-2024) & (K L)

Table 27. North America Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2025-2030) & (K L)

Table 28. North America Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2019-2024) & (K L)

Table 32. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2025-2030) & (K L)

Table 33. Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales by Region (2019-2024) & (K L)

Table 37. Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales by Region (2025-2030) & (K L)

Table 38. Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2019-2024) & (K L)

Table 42. Latin America Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2025-2030) & (K L)

Table 43. Latin America Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2019-2024) & (K L)

Table 47. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2025-2030) & (K L)

Table 48. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K L) by Type (2019-2024)

Table 51. Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K L) by Type (2025-2030)

Table 52. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Nasal Spray Live Attenuated Influenza Vaccine Price (US$/ml) by Type (2019-2024)

Table 59. Global Nasal Spray Live Attenuated Influenza Vaccine Price (US$/ml) by Type (2025-2030)

Table 60. Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K L) by Application (2019-2024)

Table 61. Global Nasal Spray Live Attenuated Influenza Vaccine Sales (K L) by Application (2025-2030)

Table 62. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Nasal Spray Live Attenuated Influenza Vaccine Price (US$/ml) by Application (2019-2024)

Table 69. Global Nasal Spray Live Attenuated Influenza Vaccine Price (US$/ml) by Application (2025-2030)

Table 70. Sanofi Pasteur Corporation Information

Table 71. Sanofi Pasteur Description and Business Overview

Table 72. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Sales (K L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)

Table 73. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product

Table 74. Sanofi Pasteur Recent Developments/Updates

Table 75. AstraZeneca Corporation Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Sales (K L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)

Table 78. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. CSL Corporation Information

Table 81. CSL Description and Business Overview

Table 82. CSL Nasal Spray Live Attenuated Influenza Vaccine Sales (K L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)

Table 83. CSL Nasal Spray Live Attenuated Influenza Vaccine Product

Table 84. CSL Recent Developments/Updates

Table 85. Abbott Corporation Information

Table 86. Abbott Description and Business Overview

Table 87. Abbott Nasal Spray Live Attenuated Influenza Vaccine Sales (K L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)

Table 88. Abbott Nasal Spray Live Attenuated Influenza Vaccine Product

Table 89. Abbott Recent Developments/Updates

Table 90. GlaxoSmithKline Corporation Information

Table 91. GlaxoSmithKline Description and Business Overview

Table 92. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Sales (K L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)

Table 93. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product

Table 94. GlaxoSmithKline Recent Developments/Updates

Table 95. Serum Institute Corporation Information

Table 96. Serum Institute Description and Business Overview

Table 97. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Sales (K L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)

Table 98. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product

Table 99. Serum Institute Recent Developments/Updates

Table 100. Fluenz Tetra Corporation Information

Table 101. Fluenz Tetra Description and Business Overview

Table 102. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Sales (K L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)

Table 103. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product

Table 104. Fluenz Tetra Recent Developments/Updates

Table 105. BioDiem Corporation Information

Table 106. BioDiem Description and Business Overview

Table 107. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Sales (K L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)

Table 108. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product

Table 109. BioDiem Recent Developments/Updates

Table 110. FluMist Corporation Information

Table 111. FluMist Description and Business Overview

Table 112. FluMist Nasal Spray Live Attenuated Influenza Vaccine Sales (K L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)

Table 113. FluMist Nasal Spray Live Attenuated Influenza Vaccine Product

Table 114. FluMist Recent Developments/Updates

Table 115. ChangChun High & New Technology Corporation Information

Table 116. ChangChun High & New Technology Description and Business Overview

Table 117. ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Sales (K L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)

Table 118. ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Product

Table 119. ChangChun High & New Technology Recent Developments/Updates

Table 120. BCHT Biotechnology Corporation Information

Table 121. BCHT Biotechnology Description and Business Overview

Table 122. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Sales (K L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)

Table 123. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product

Table 124. BCHT Biotechnology Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Nasal Spray Live Attenuated Influenza Vaccine Distributors List

Table 128. Nasal Spray Live Attenuated Influenza Vaccine Customers List

Table 129. Nasal Spray Live Attenuated Influenza Vaccine Market Trends

Table 130. Nasal Spray Live Attenuated Influenza Vaccine Market Drivers

Table 131. Nasal Spray Live Attenuated Influenza Vaccine Market Challenges

Table 132. Nasal Spray Live Attenuated Influenza Vaccine Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Nasal Spray Live Attenuated Influenza Vaccine

Figure 2. Global Nasal Spray Live Attenuated Influenza Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Nasal Spray Live Attenuated Influenza Vaccine Market Share by Type in 2023 & 2030

Figure 4. Trivalent Flu Vaccine Product Picture

Figure 5. Quadrivalent Flu Vaccine Product Picture

Figure 6. Global Nasal Spray Live Attenuated Influenza Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Nasal Spray Live Attenuated Influenza Vaccine Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Public Health Agency

Figure 11. Others

Figure 12. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size (2019-2030) & (US$ Million)

Figure 14. Global Nasal Spray Live Attenuated Influenza Vaccine Sales (2019-2030) & (K L)

Figure 15. Global Nasal Spray Live Attenuated Influenza Vaccine Average Price (US$/ml) & (2019-2030)

Figure 16. Nasal Spray Live Attenuated Influenza Vaccine Report Years Considered

Figure 17. Nasal Spray Live Attenuated Influenza Vaccine Sales Share by Manufacturers in 2023

Figure 18. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Nasal Spray Live Attenuated Influenza Vaccine Players: Market Share by Revenue in 2023

Figure 20. Nasal Spray Live Attenuated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Nasal Spray Live Attenuated Influenza Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country (2019-2030)

Figure 23. North America Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Country (2019-2030)

Figure 24. United States Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country (2019-2030)

Figure 27. Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Country (2019-2030)

Figure 28. Germany Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Region (2019-2030)

Figure 35. China Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country (2019-2030)

Figure 45. Latin America Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Nasal Spray Live Attenuated Influenza Vaccine by Type (2019-2030)

Figure 55. Global Revenue Market Share of Nasal Spray Live Attenuated Influenza Vaccine by Type (2019-2030)

Figure 56. Global Nasal Spray Live Attenuated Influenza Vaccine Price (US$/ml) by Type (2019-2030)

Figure 57. Global Sales Market Share of Nasal Spray Live Attenuated Influenza Vaccine by Application (2019-2030)

Figure 58. Global Revenue Market Share of Nasal Spray Live Attenuated Influenza Vaccine by Application (2019-2030)

Figure 59. Global Nasal Spray Live Attenuated Influenza Vaccine Price (US$/ml) by Application (2019-2030)

Figure 60. Nasal Spray Live Attenuated Influenza Vaccine Value Chain

Figure 61. Nasal Spray Live Attenuated Influenza Vaccine Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions